NCT01884168View on ClinicalTrials.gov

Study of Gene Expression Profiling and Immunological Mechanism Affects the Response of Immunotherapy

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

December 31, 2022

Study Completion Date

May 31, 2023

Conditions
Malignant Tumor
Interventions
BIOLOGICAL

Dc-CIK immunotherapy

The patients with malignant cavity effusion are treated with dendritic cells (DC) plus cytokine induced killer cells (CIK) locally.

Trial Locations (1)

100038

Capital Medical University Cancer Center/Beijing Shijitan Hospital, Beijing

All Listed Sponsors
lead

Capital Medical University

OTHER

NCT01884168 - Study of Gene Expression Profiling and Immunological Mechanism Affects the Response of Immunotherapy | Biotech Hunter | Biotech Hunter